CohBar Company

CohBar is a clinical stage biotechnology company whose mission is to increase healthy lifespan by developing treatments for the underlying metabolic dysfunction driving the diseases of aging including NASH, obesity, cancer, Type 2 diabetes, and cardiovascular and neurodegenerative diseases.
CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepatitis (NASH), obesity, Type 2 diabetes (T2D), cancer, cardiovascular disease and CNS disorders.
Technology: Mitochondrial Disorders
Industry: Geroscience
Headquarters: United States
Founded Date: 2007
Employees Number: 1-10
Funding Status: IPO
Total Funding: $450K
Estimated Revenue: Less than $1M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership